United States · FDA National Drug Code directory
Tetrabenazine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 31722-821_3a2ffa8c-f4c5-47e2-8775-5d0edfa55658
- Product NDC
- 31722-821
- Form
- TABLET, COATED
- Composition / generic term
- Tetrabenazine
- Labeler
- Camber Pharmaceuticals, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20150817
- Source listing expiry
- 20261231
Source-listed ingredients
- TETRABENAZINE — 12.5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 112 TABLET, COATED in 1 BOTTLE (31722-821-11) · 31722-821-11
- 10 TABLET, COATED in 1 BLISTER PACK (31722-821-31) · 31722-821-31
- 100 TABLET, COATED in 1 CARTON (31722-821-32) · 31722-821-32
- 56 TABLET, COATED in 1 BOTTLE (31722-821-56) · 31722-821-56
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →